Search - tctmd.com

Displaying 101 - 120 of 39119

Sort: Relevancy | Date

Presentation THT 2026

Psoas Muscle Recovery After LVAD Implantation is Associated with Decreased Risk of Heart Failure Readmission in Cardiogenic Shock Patients

Presenter: Robert Anthony Adamian

March 03, 2026

Presentation THT 2026

LVEF and Functional Improvement Observed in a Post-Market Registry of Barostim Baroreflex Activation Therapy

Presenter: Dmitry Yaranov

March 03, 2026

Presentation THT 2026

Cardiomechanics Before and After mTEER: Insights From Pressure-Volume Analysis

Presenter: Nicolas M. Van Mieghem

March 03, 2026

Presentation THT 2026

Levosimendan: Mechanisms and Clinical Effects as a Treatment for PH-HFpEF

Presenter: Sanjiv J. Shah

March 03, 2026

Presentation THT 2026

Real-World Outcomes of Barostim Baroreflex Activation Therapy in Heart Failure: Analysis of a Large Multi-Institutional Database.

Presenter: Arvind Bhimaraj

March 03, 2026

Presentation THT 2026

Baseline Characteristics and Outcomes in Patients Presenting with Cardiogenic Shock: A Single-Center Cohort Study

Presenter: Michael Daidone

March 03, 2026

Presentation THT 2026

Exercise-Induced MR: Implications for Diagnosis and Treatment

Presenter: Nikhil Narang

March 03, 2026

Presentation THT 2026

Impact of Pharmacist Virtual Consultation on GDMT Optimization in Hospitalized Patients

Presenter: Brad Williams

March 03, 2026

Presentation THT 2026

Cardiogenic Shock with Cardiac Arrest: Does It Always Represent SCAI Stage E?

Presenter: Maya Guglin

March 03, 2026

Presentation THT 2026

Ultrasound Pulmonary Artery Denervation as a Treatment for Heart Failure (Gradient Medical)

Presenter: Alex Rothman

March 03, 2026

Presentation THT 2026

Medical Therapy for TR

Presenter: Sean P. Pinney

March 03, 2026

Presentation THT 2026

Anatomic Considerations for T-TEER and TTVR

Presenter: Jörg Hausleiter

March 03, 2026

Presentation THT 2026

Supervised Learning vs. Foundation Models: A Comparative Appraisal of PanEcho and EchoPrime for Heart Failure Phenotyping

Presenter: Ahmad Nusairat

March 03, 2026

Presentation THT 2026

Comorbidity Burden and 30-Day Readmission After Cardiogenic Shock: Predictive Limits of Established Indices

Presenter: Ronit Kar

March 03, 2026

Presentation THT 2026

Radiofrequency Pulmonary Artery Denervation for Heart Failure (Pulnovo)

Presenter: Giora Weisz

March 03, 2026

Presentation THT 2026

Real-World Comparison of Finerenone and Steroidal Mineralocorticoid Receptor Antagonists in Patients With Heart Failure With Reduced Ejection Fraction

Presenter: Thitiphan Srikulmontri

March 03, 2026

Presentation THT 2026

Prognostic Utility of Serum Lactate Dynamics for In-Hospital Mortality in Cardiogenic Shock: A Single Hub Regional Center Analysis

Presenter: Raul R. Neri Bale

March 03, 2026

Presentation THT 2026

An Emerging Problem: TR in Advanced Heart Failure (LVAD, OHT) Patients

Presenter: Michael I. Brener

March 03, 2026

Presentation THT 2026

Splanchnic Nerve Ablation for Treatment of HF Across the Spectrum of LV EFs

Presenter: Parag Goyal

March 03, 2026

Presentation THT 2026

Novel Prediction Model for In-Hospital Mortality in Cardiogenic Shock Patients

Presenter: Michael Daidone

March 03, 2026

Advertisement

Psoas Muscle Recovery After LVAD Implantation is Associated with Decreased Risk of Heart Failure Readmission in Cardiogenic Shock Patients

LVEF and Functional Improvement Observed in a Post-Market Registry of Barostim Baroreflex Activation Therapy

Cardiomechanics Before and After mTEER: Insights From Pressure-Volume Analysis

Levosimendan: Mechanisms and Clinical Effects as a Treatment for PH-HFpEF

Real-World Outcomes of Barostim Baroreflex Activation Therapy in Heart Failure: Analysis of a Large Multi-Institutional Database.

Baseline Characteristics and Outcomes in Patients Presenting with Cardiogenic Shock: A Single-Center Cohort Study

Exercise-Induced MR: Implications for Diagnosis and Treatment

Impact of Pharmacist Virtual Consultation on GDMT Optimization in Hospitalized Patients

Cardiogenic Shock with Cardiac Arrest: Does It Always Represent SCAI Stage E?

Ultrasound Pulmonary Artery Denervation as a Treatment for Heart Failure (Gradient Medical)

Medical Therapy for TR

Anatomic Considerations for T-TEER and TTVR

Supervised Learning vs. Foundation Models: A Comparative Appraisal of PanEcho and EchoPrime for Heart Failure Phenotyping

Comorbidity Burden and 30-Day Readmission After Cardiogenic Shock: Predictive Limits of Established Indices

Radiofrequency Pulmonary Artery Denervation for Heart Failure (Pulnovo)

Real-World Comparison of Finerenone and Steroidal Mineralocorticoid Receptor Antagonists in Patients With Heart Failure With Reduced Ejection Fraction

Prognostic Utility of Serum Lactate Dynamics for In-Hospital Mortality in Cardiogenic Shock: A Single Hub Regional Center Analysis

An Emerging Problem: TR in Advanced Heart Failure (LVAD, OHT) Patients

Splanchnic Nerve Ablation for Treatment of HF Across the Spectrum of LV EFs

Novel Prediction Model for In-Hospital Mortality in Cardiogenic Shock Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content